Adult travelers with HIV infection

Journal of Travel Medicine

Volumn 4, Issue 3, 1997, Pages 136-143

  Van Gompel, Alfons ^a   Kozarsky, Phyllis ^b   Colebunders, Robert ^c  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNIZATION; INFECTION RISK; INFLUENZA VACCINATION; LOBAR PNEUMONIA; PATIENT COUNSELING; REVIEW; TRAVEL;

EID: 0030824682     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1997.tb00801.x     Document Type: Review

References (116)

1. Kemper CA, Linett A, Kane C, Deresinski SC. Frequency of travel of adults infected with HIV. J Travel Med 1995;2:85-88.
2. Kemper CA, Kane C, Griffiths D, et al. Motivation for travel and effect on health of HIV-infected persons. Third Conference on International Travel Medicine, Paris, 1993; abstract 313:238.
3. Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis 1987; 156:84-90.
4. Steffen R, Lobel OH. Travel medicine. In: Cook GC, ed. Manson's tropical diseases. 20th Ed. London: Saunders, 1996: 407-420.
5. Wilson ME, Fordham von Reyn C, Finberg HV. Infections in HIV-infected travelers: risks and prevention. Ann Intern Med 1991;114:582-592.
6. Wilson ME. Geographically focal infections and the HIV-infected travelers. Proceedings of the Second Conference on International Travel Medicine. Atlanta, Georgia, USA. 1991;218-219.
7. Parenti DM.The international traveler and HIV infection. In:Travel Medicine Advisor 1992;10.1-10.13.
8. Bollinger RC, Quinn TC. In: Tropical diseases in the HIV-infected traveler. Broder S, Merigan TC, Bolognesi D, eds. Textbook of AIDS medicine. Baltimore: Williams & Wilkins, 1994:311-322.
9. Murillo J, Castro KG. HIV infection and AIDS in Latin America. Infect Dis Clin North Am 1994;8:1-11.
10. Kaplan JE, Masur H, Holmes K. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. Clin Infect Dis 1995;21(Suppl):S12-31.
11. Smith PD. Intestinal infections in HIV-1 disease. In: Blaser MJ, Smith PD, Ravdin JI, et al., eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:483-498.
12. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993;328:1821-1827.
13. Wittner M, Tanowitz HB, Weiss LM. Parasitic infections in AIDS patients. Infect Dis Clin North Am 1993;7:569-586.
14. Mayer HB, Wanke CA. Diagnostic strategies in HIV-infected patients with diarrhea. AIDS 1994;8:1639-1648.
15. Angulo FJ, Swerdlow DL. Bacterial enteric infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21(Suppl 1):S84-93.
16. Gotuzzo E, Frisancho O, Sanchez J, et al. Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch Intern Med 1991;151:381-382.
17. Lockwood DNJ, Weber JN. Parasite infections in AIDS. Parasitol Today 1989;5:310-316.
18. Fleming AF. Opportunistic infections in AIDS in developed and developing countries. Trans R Soc Trop Med Hyg 1990; 84:1-6.
19. Lucas SB. Missing infections in AIDS. Trans R Soc Trop Med Hyg 1990;84:34-38.
20. Schlamm HT, Yancovitz SR. Haemophilus influenza pneumonia in young adults with AIDS, ARC, or risk of AIDS. Am J Med 1989;86:11-14.
21. Redd SC, Rutherford GW III, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990;162: 1012-1017.
22. Wallace JM, Rao AV, Glassroth J, et al. Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis 1993;148:1523-1529.
23. Caiaffa WT, Graham NM, Vlahov D. Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol 1994;138:909-922.
24. Hirschtick RE, Glassroth J, Jordan MC. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995;333:845-851.
25. Chaisson R. Mycobacterial infections and HIV. Curr Opin Infect Dis 1993;6:237-243.
26. Blatt SP, Dolan MJ, Hendrix CW, Melcher GP. Legionnaires' disease in human immunodeficiency virus-infected patients: eight cases and review. Clin Infect Dis 1994;18:227-232.
27. Rodero FG, Ortiz de la Tabla V, Martinez C, et al. Legionnaires' diseases in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;21:712-713.
28. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992; 267(9):1237-1241.
29. Wong Rd, Bidwell Goetz M, Mathisen G, Henry D. Clinical and laboratory features in measles in hospitalized adults. Am J Med 1993;95:337-383.
30. Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev 1995;8:146-159.
31. Levitz SM.The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991;13: 1163-1169.
32. Pinner RW, Hajjeh RA, Powderly WG. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21(Suppl 1):S103-S107.
33. Jones JL, Fleming PL, Ciesielski CA, et al. Coccidiomycosis among persons with AIDS in the United States. J Infect Dis 1995;171:961-966.
34. Stevens DA. Coccidiomycosis. N Engl J Med 1995;332: 1077-1082.
35. McNeil MM, Ampel NM. Opportunistic coccidiomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 1995;21 (Suppl 1):S111-S113.
36. Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992;116:847-853.
37. Colebunders R, Van den Abbeele K, Hauben E, et al. Histoplasma capsulatum infection in three AIDS patients living in Africa. Scand J Infect Dis 1995;27:89-91.
38. Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med 1995;98:336-342.
39. Hajjeh RA. Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(Suppl 1):S108-S110.
40. Hilmarsdottir I, Meynard JL, Rogeaux O, et al. Disseminated Penicillium marnefii infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases. J Acquir Immune Defic Syndr 1993;6: 466-471.
41. Hill R. Disseminated infection with Penicillium marnefii: abstract & commentary. Travel Med Adv Update 1994;41:1-3.
42. Kok I, Veenstra J, Rietra PJGM, et al. Disseminated Penicillium marneffei infection as an imported disease in HIV-1 infected patients. Neth J Med 1994;44:18-22.
43. Raoult D, Levy PY, Tissot Dupont H, et al. Q fever and HIV infection. AIDS 1993;7:81-85.
44. Montes M, Cilla G, Marimon JM, et al. Coxiella burnetti infection in subjects with HIV infection and HIV infection in patients with Q fever. Scand J Infect Dis 1995;27:344-346.
45. Aguado JM, Vada J, Zuniga M. Meningococcemia: an undescribed cause of community-acquired bacteremia in patients with acquired immunodeficiency symdrome (AIDS) and AIDS-related complex. Am J Med 1990;88:314.
46. Nitta AT, Douglas JM, Arakere G, Ebens JB. Disseminated meningococcal infection in HIV-seropositive patients. AIDS 1993;7:87-90.
47. Stephens DS, Hajjeh RA, Baughman WS, et al. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med 1995;123:937-940.
48. Wright JP, Ford HL. Bacterial meningitis in developing countries. Trop Doct 1995;25:5-8.
49. Pinner RW, Onyango F, Perkins BA. Epidemic meningococcal disease in Nairobi, Kenya, 1989. J Infect Dis 1992;166: 359-364.
50. Kipp W, Kamugisha J, Rehle T. Meningococcal meningitis and HIV infection: results from a case-control study in western Uganda. AIDS 1992;6:1557-1558.
51. Koch S, Steffen R. Meningococcal disease in travelers: vaccination recommendations. J Travel Med 1994;1:4-7.
52. ACIP. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices. MMWR 1995;44(RR-3):1-22.
53. Laga M, Diallo MO, Buvé A. Inter-relationship of sexually transmitted diseases and HIV: Where are we now? AIDS 1994;8(Suppl 1):S119-124.
54. Wright TK, Lau JY. Clinical aspects of hepatitis B virus infection. Lancet 1993;342:1340-1344.
55. Alvar J. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol Today 1994;10:160-163.
56. Montalban C, Calleja JL, Erice A, et al. Visceral leishmaniasis in patients infected with the human immunodeficiency virus. J Infect 1990;21:261-270.
57. Dereure J, Reynes J, Pratlong F, et al. Visceral leishmaniasis in HIV-infected patients in the south of France. Bull World Health Organ 1995;73:245-246.
58. Dedet JP, Lambert M, Pratlong F. Leishmanioses et infection par le virus de l'immunodeficience humaine. Presse Med 1995; 24:1036-1040.
59. Rosenthal E, Marty P, Poizot-Martin I, et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 1995;89:159-162.
60. Report on the Consultative Meeting on Leishmania/HIV Co-Infection. WHO/LEISH 1994;95.35:1-14.
61. Cnudde F, Boulard F, Raccurt CP, et al. Leishmaniose cutanee diffuse avec dissemination viscerale chez un Haitien vivant en Guadeloupe, atteint de SIDA. Nouv Dermatol 1995;14:61-64.
62. Gradoni L, Gramiccia M. Fatal visceral diseases caused by a dermotropic leishmania in a patient with human immunodeficiency virus infection. J Infect 1989;20:180-182.
63. Marty P, Fuzibet JG, Pratlong F, et al. Leishmaniose viscerale causee par une souche dermotrope de leishmania infantum chez un Sideen. Bull Soc Pathol Exot 1991;84:365-367.
64. Solari A, Saavedra H, Sepulveda C, et al. Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. Clin Infect Dis 1993;16:255-259.
65. Gluckstein D, Ciferri F, Ruskin J. Chagas' disease: another cause of cerebral mass in the acquired immunodeficiency syndrome. Am J Med 1992;92:429-432.
66. Rocha A. Oliveira de Meneses AC, Moreira da Silva A, et al. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 1994; 50:261-268.
67. Evans TG, Wright J, Hale D, Ricks JH. Risk of leishmaniasis and Chagas' disease in missionaries to Central and South America. Proceedings of the Second Conference on International Travel Medicine. Atlanta, Georgia, USA 1991:27-28.
68. Müller O, Moser R. The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection. Trans R Soc Trop Med Hyg 1990;84: 336-338.
69. Colebunders R, Bahwe Y, Nekwei W, et al. Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. J Infect 1990;21:167-173.
70. Simooya OO, Mwendapole RM, Sikateyo BM. Severe falciparum malaria and the acquired immunodeficiency syndrome (AIDS) in Zambia. Ann Trop Med Parasitol 1991;85: 269-270.
71. Leaver RJ, Haile Z, Watters DA. HIV and cerebral malaria. Trans R Soc Trop Med Hyg 1990;84:201.
72. Greenberg AE, Nsa W, Wato Nsa MD, et al. Plasmodium falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. N Engl J Med 1992;325:105-109.
73. Meda HA, Doua F, Laveissière C, et al. Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire. Trans R Soc Trop Med Hyg 1995;89:639-643.
74. Sow MT, Gabriel JM, Strobel, et al. Anguilloulose et infection a VIH. Bull Soc Pathol Exot 1993;509-510.
75. Torres JR, Isturiz R, Murillo J, et al. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis 1993;17:900-902.
76. Veas F, Rey JL. Infection a VIH et parasitoses en zone tropicale. Cahiers Sante 1991;1:189-201.
77. N'Zoukoudi-N'Doundou MY, Dirat I, Akouala JJ, et al. Bilharziose et infection par le virus de l'immunodeficience humaine au Congo. Med Trop 1995;55:249-251.
78. Lucas S. Human immunodeficiency virus and leprosy. Lepr Rev 1993;64:97-103.
79. Frommel D, Tekle-Haimanot R, Verdier M, et al. HIV Infection and leprosy: a four-year survey in Ethiopia. Lancet 1994; 344:165-166.
80. Naafs B, Chin-A-Lien RAM, Tank B, van Joost T. Human immunodeficiency virus and leprosy. Trop Geogr Med 1994; 2:119-121.
81. Meeran K. Prevalence of HIV infection among patients with leprosy and tuberculosis in rural Zambia. BMJ 1989;298: 364-365.
82. Borgdorff MW, van den Broek J, Chum HJ, et al. HIV-1 infection as a risk factor for leprosy: a case-control study in Tanzania. Int J Lepr 1993;61:556-561.
83. Orege PA, Fine PEM, Lucas SB, et al. A case control study on HIV-1 infection as a risk factor for tuberculosis and leprosy in Western Kenya. Tuber Lung Dis 1993;74:377-381.
84. Fiallo P, Nunzi E, Bisighini G, Vaccouri G. Leprosy in an Italian tourist visiting the tropics. Trans R Soc Trop Med Hyg 1993;87:685.
85. Schwartz JS, Bencowitz HZ, Moser KM. Air travel hypoxemia with chronic obstructive pulmonary disease. Ann Intern Med 1984;100:473-477.
86. Godofsky EW, Zinreich J, Armstrong M, et al. Sinusitis in HIV-infected patients: a clinical and radiographic review. Am J Med 1992;93:163-169.
87. Zurlo JJ, Feuerstein IM, Lebovics R, et al. Sinusitis in HIV-1 infection. Am J Med 1992;93:157-162.
88. Wilson ME. Use of vaccines in the HIV-infected travelers. Proceedings of the Second Conference on International Travel Medicine. Atlanta, Georgia, USA 1991:216-217.
89. ACIP. Recommendations of the Advisory Committee on Immunization Practices: Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 1993;42(RR-4):1-18.
90. Redfield RR, Wright DC, James WD, et al. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 1987;316:673-676.
91. Halsey NA, Henderson DA. HIV infection and immunization against other agents. N Engl J Med 1987;316(11): 683-685.
92. Weltman AC, Rose DN. The safety of bacille Calmette-Guérin vaccination in HIV infection and AIDS. AIDS 1993;7: 149-157.
93. van Deutekim H, Smulders YM, Roozendaal KJ, et al. Bacille Calmette-Guérin (BCG) meningitis in an AIDS patient 12 years after vaccination with BCG. Clin Infect Dis 1996;22: 870-871.
94. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-1230.
95. Cheeseman SH, Davaro RE, Ellison RD III. Hepatitis B vaccination and plasma HIV-1 RNA. N Engl J Med 1996;334: 1272.
96. Ramillo O, Hicks PJ, Borvak J. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infec Dis J 1996;15: 197-203.
97. Huang KL, Ruben FL, Rinaldo CR, et al. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA 1987;257:2047-2050.
98. Klein RS, Selwyn PA, Maude D, et al. Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. J Infect Dis 1989;160: 826-831.
99. La Montagne JR. Immunization programs and HIV. Rev Infect Dis 1989;11(Suppl 3):S639-643.
100. Vandenbruaene M, Colebunders R, Mascart-Lemone F, et al. Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease. J Infect Dis 1995;172:551-553.
101. McDonald P, Lighton L, Anderson R. Pneumococcal vaccine for HIV patients. BMJ 1995;311:387-388.
102. Glaser JB, Volpe S, Aguirre A, et al. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 1991;164: 761-764.
103. Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994;8(4):469-476.
104. Guide for adult immunization, 3rd Ed. Philadelphia, Pennsylvania:The American College of Physicians, HIV Infection and the Acquired Immunodeficiency Syndrome, 1994:50-53.
105. Steinhoff MC, Auerbach BS, Nelson KE, et al. Antibody responses to Haemophilus influenzae type B vaccine in men with human immunodeficiency virus infection. N Engl J Med 1991;325:1837-1842.
106. Kurtzhals JAL, Kjeldsen K, Heron I, Skinhoj P. Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS 1992;100: 803-808.
107. Lutwick LI, Chapnick EK, Gradon JD, Shirazian D. Measles vaccination in a small cohort of HIV-infected adults. Infect Dis Clin Pract 1993;2:123-125.
108. Sha BE, Harris AA, Benson CA, et al. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis 1991;164:973-975.
109. Zolopa AR, Kemper CA, Shiboski S, et al. Progressive immunodeficiency due to infection with human immunodeficiency virus does not lead to waning immunity to measles in a cohort of homosexual men. Clin Infect Dis 1994;18:636-638.
110. Goujon C, Tohr M, Feuillie V, et al. Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus. J Travel Med 1995;2:145.
111. Santagostino E, Gringeri A, Rocino A, et al. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophiliac patients. Thromb Haemost 1994;72:508-510.
112. Hess G, Bienzle U, Schunk B, et al. Immunization against hepatitis A in HIV positive and negative homosexual subjects. International Symposium on Viral Hepatitis and Liver Disease. The 8thTriennial Congress, Tokyo Japan. 1993;Abstract 041.
113. Clemens R, Safary A, Hepburn A, et al. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995; 171(Suppl 1):S44-49.
114. Rhoads JL, Birx DL, Wright DC, et al. Safety and immunogenicity of multiple conventional immunizations administered during early HIV infections. J Acquir Immune Defic Syndr 1991;4:724-731.
115. Duckett M, Orkin AJ. AIDS-related migration and travel policies and restrictions: a global survey. AIDS 1989;3 (Suppl 1):S231-252.
116. Mann JM, Tanartola DJM, eds. AIDS in the world II. New York: Oxford University Press, 1996.